Bernard R Rubin, DO | |
3031 W Grand Blvd, Rheumatology - Nco 8, Detroit, MI 48202-3046 | |
(313) 916-2646 | |
Not Available |
Full Name | Bernard R Rubin |
---|---|
Gender | Male |
Speciality | Internal Medicine - Rheumatology |
Location | 3031 W Grand Blvd, Detroit, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609830397 | NPI | - | NPPES |
660000436 | Other | TX | RAILROAD MEDICARE PIN |
842571 | Other | TX | BCBS |
125067203 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 5101019001 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bernard R Rubin, DO 3031 W Grand Blvd, Rheumatology - Nco 8, Detroit, MI 48202-3046 Ph: (313) 916-2646 | Bernard R Rubin, DO 3031 W Grand Blvd, Rheumatology - Nco 8, Detroit, MI 48202-3046 Ph: (313) 916-2646 |
News Archive
Women who engaged in the most activity - for example, walking at least 6 hours per week - had a 20 percent decrease in risk of cognitive impairment compared to those who were inactive and, also demonstrated the cognitive functioning of someone three-years younger than their actual age.
Millions of people in the United States suffer from a medical condition that can unpredictably cause them to begin sweating as if they had just finished running a marathon.Hyperhidrosis, or excessive sweating, is a common disorder that first becomes noticeable during childhood or adolescence. People with hyperhidrosis could be doing something as leisurely as lying down or watching television and sweat will still soak their bodies.
Paxman Coolers Limited announced today that The U.S. Food and Drug Administration (FDA) has cleared the company to market the Paxman Scalp Cooling System, a scalp cooling technology that was developed by a British family to reduce hair loss in breast cancer patients undergoing chemotherapy.
Women with a particularly aggressive form of breast cancer seem to do better if they are treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (Herceptin) before and after surgery, according to results from the largest multi-centre trial to investigate this treatment.
Threshold Pharmaceuticals, Inc. today announced that it has initiated a multi-center, randomized, controlled, crossover Phase 2 clinical trial of TH-302 in combination with gemcitabine in patients with first line pancreatic cancer. TH-302 is a proprietary tumor selective Hypoxia-Activated Prodrug that specifically targets tumor hypoxia.
› Verified 5 days ago
Dr. Saba Alan Francis, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Rheumatology Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |